Finasteride Gambar
22 gambar dari penelitian yang ditinjau oleh rekan sejawat
Treatment options for androgenetic alopecia range from FDA-approved pharmacological agents (minoxidil and finasteride) to emerging therapies including low-level laser therapy, platelet-rich plasma, and hair transplantation. Efficacy, side effect profiles, and patient compliance vary substantially across modalities.
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and …
The CONSORT (Consolidated Standards of Reporting Trials) flow diagram documents the systematic review process from identification through screening, eligibility assessment, and final inclusion of studies evaluating PRP for androgenetic alopecia.
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, …
A clinical photograph demonstrating female pattern hair loss, showing characteristic diffuse thinning across the crown and mid-scalp. FPHL affects women with varying degrees of severity and may lead to significant psychological distress.
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
The Ludwig scale classifies female pattern hair loss into three progressive stages, ranging from minimal thinning at the crown (Grade I) to extensive hair loss across the top of the scalp (Grade III). This grading system remains one of the most widely used clinical tools for assessing FPHL severity.
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
Sinclair's classification divides midline pattern alopecia into four intensity levels, progressing from a normal-appearing scalp to increasingly visible widening of the central part. The scale, introduced by Sinclair et al. (2005), provides a practical visual reference for clinicians assessing hair loss severity.
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
Olsen's classification system highlights the characteristic triangular or Christmas-tree pattern of frontovertical alopecia seen in female pattern hair loss. The accentuation of thinning at the frontal midline distinguishes this pattern from the more diffuse Ludwig classification.
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
The finasteride 0.25% topical spray applicator and its mode of administration on the scalp are depicted. Developed to minimize systemic exposure compared with oral finasteride, the spray formulation targets hair follicles directly for treatment of male androgenetic alopecia.
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: …
Results from a phase III randomized controlled trial compare the efficacy of topical finasteride spray versus placebo in men with androgenetic alopecia. The data indicate changes in hair count or density over the treatment period, with topical finasteride associated with reduced systemic exposure relative to the oral formulation.
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: …
Classification systems for androgenetic alopecia severity are presented, distinguishing male and female pattern hair loss stages.
Androgenetic alopecia: An update.
The DHT synthesis pathway via SRD5A2 is diagrammed, showing how 5-alpha reductase converts testosterone to dihydrotestosterone in the presence of NADPH, the key hormonal driver of AGA.
Androgenetic alopecia: An update.
Finasteride's mechanism of inhibition is depicted at the molecular level, showing covalent adduct formation between NADPH and finasteride that prevents further hydride transfer to testosterone.
Androgenetic alopecia: An update.
The three-dimensional structure of human SRD5A2 is shown with its seven transmembrane domains, active site, and NADP-DHF adduct positioning within the enzyme channel.
Androgenetic alopecia: An update.
Experimental findings on adverse effects of 5-alpha-reductase inhibitors in animal models are summarized, providing mechanistic insights into how these drugs may affect the central and peripheral nervous systems.
Post-finasteride syndrome: An emerging clinical problem.
Proposed pathophysiological mechanisms underlying the persistent side effects of finasteride are outlined, connecting hormonal disruption to epigenetic changes and altered gut microbiota composition.
Post-finasteride syndrome: An emerging clinical problem.
Side effects of treatment with 5-alpha-reductase inhibitors observed in experimental models are comprehensively catalogued, covering reproductive, neurological, and metabolic endpoints.
Post-finasteride syndrome: An emerging clinical problem.
A proposed treatment algorithm for female pattern hair loss incorporates finasteride as a potential alternative when topical minoxidil fails, including appropriate patient selection criteria and monitoring requirements.
Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: …
Forest plot from the meta-analysis comparing dutasteride versus finasteride for hair count improvement in men with androgenetic alopecia over a 24-week treatment period.
The efficacy and safety of dutasteride compared with finasteride in treating men …
Epidemiological landscape of androgenetic alopecia in the US: An All of Us …
Epidemiological landscape of androgenetic alopecia in the US: An All of Us …
Epidemiological landscape of androgenetic alopecia in the US: An All of Us …
Fig 4. Likelihood of AGA reporting for females by comorbid condition. All data is represented as odds ratios of the condition compared to control with corresponding p-value and interpretation.
Epidemiological landscape of androgenetic alopecia in the US: An All of Us …